960 related items for PubMed ID: 26668027
1. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
Büscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, Baig S, Lange-Sperandio B, Jungraithmayr T, Weber LT, Kemper MJ, Tönshoff B, Hoyer PF, Konrad M, Weber S, German Pediatric Nephrology Association (GPN).
Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):245-53. PubMed ID: 26668027
[Abstract] [Full Text] [Related]
2. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.
Büscher AK, Kranz B, Büscher R, Hildebrandt F, Dworniczak B, Pennekamp P, Kuwertz-Bröking E, Wingen AM, John U, Kemper M, Monnens L, Hoyer PF, Weber S, Konrad M.
Clin J Am Soc Nephrol; 2010 Nov 05; 5(11):2075-84. PubMed ID: 20798252
[Abstract] [Full Text] [Related]
3. Steroid-resistant nephrotic syndrome: impact of genetic testing.
Kari JA, El-Desoky SM, Gari M, Malik K, Vega-Warner V, Lovric S, Bockenhauer D.
Ann Saudi Med; 2013 Nov 05; 33(6):533-8. PubMed ID: 24413855
[Abstract] [Full Text] [Related]
4. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
Bierzynska A, McCarthy HJ, Soderquest K, Sen ES, Colby E, Ding WY, Nabhan MM, Kerecuk L, Hegde S, Hughes D, Marks S, Feather S, Jones C, Webb NJ, Ognjanovic M, Christian M, Gilbert RD, Sinha MD, Lord GM, Simpson M, Koziell AB, Welsh GI, Saleem MA.
Kidney Int; 2017 Apr 05; 91(4):937-947. PubMed ID: 28117080
[Abstract] [Full Text] [Related]
5. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM, Catarsi P, Scolari F, Caridi G, Bertelli R, Carrea A, Sanna-Cherchi S, Emma F, Allegri L, Cancarini G, Rizzoni GF, Perfumo F.
Clin Ther; 2004 Sep 05; 26(9):1411-8. PubMed ID: 15531003
[Abstract] [Full Text] [Related]
6. Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible.
Klaassen I, Özgören B, Sadowski CE, Möller K, van Husen M, Lehnhardt A, Timmermann K, Freudenberg F, Helmchen U, Oh J, Kemper MJ.
Pediatr Nephrol; 2015 Sep 05; 30(9):1477-83. PubMed ID: 25903641
[Abstract] [Full Text] [Related]
7. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
Ramanathan AS, Vijayan M, Rajagopal S, Rajendiran P, Senguttuvan P.
Mol Cell Biochem; 2017 Feb 05; 426(1-2):177-181. PubMed ID: 27885584
[Abstract] [Full Text] [Related]
8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov 05; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
9. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Özkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Özcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F, PodoNet Consortium.
Clin J Am Soc Nephrol; 2015 Apr 07; 10(4):592-600. PubMed ID: 25635037
[Abstract] [Full Text] [Related]
10. Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.
Suvanto M, Patrakka J, Jahnukainen T, Sjöström PM, Nuutinen M, Arikoski P, Kataja J, Kestilä M, Jalanko H.
Clin Exp Nephrol; 2017 Aug 07; 21(4):677-684. PubMed ID: 27573339
[Abstract] [Full Text] [Related]
11. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).
Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F, Arbeitsgemeinschaft für Paediatrische Nephrologie Study Group.
Pediatrics; 2007 Apr 07; 119(4):e907-19. PubMed ID: 17371932
[Abstract] [Full Text] [Related]
12. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F, Arbeitsgemeinschaft Für Pädiatrische Nephrologie Study Group.
J Am Soc Nephrol; 2004 Mar 07; 15(3):722-32. PubMed ID: 14978175
[Abstract] [Full Text] [Related]
13. Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.
Nandlal L, Winkler CA, Bhimma R, Cho S, Nelson GW, Haripershad S, Naicker T.
Eur J Pediatr; 2022 Oct 07; 181(10):3595-3606. PubMed ID: 35920919
[Abstract] [Full Text] [Related]
14. Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome.
Wang F, Zhang Y, Mao J, Yu Z, Yi Z, Yu L, Sun J, Wei X, Ding F, Zhang H, Xiao H, Yao Y, Tan W, Lovric S, Ding J, Hildebrandt F.
Pediatr Nephrol; 2017 Jul 07; 32(7):1181-1192. PubMed ID: 28204945
[Abstract] [Full Text] [Related]
15. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.
Santín S, Bullich G, Tazón-Vega B, García-Maset R, Giménez I, Silva I, Ruíz P, Ballarín J, Torra R, Ars E.
Clin J Am Soc Nephrol; 2011 May 07; 6(5):1139-48. PubMed ID: 21415313
[Abstract] [Full Text] [Related]
16. Report of novel genetic variation in NPHS2 gene associated with idiopathic nephrotic syndrome in South Indian children.
Dhandapani MC, Venkatesan V, Rengaswamy NB, Gowrishankar K, Ekambaram S, Sengutavan P, Perumal V.
Clin Exp Nephrol; 2017 Feb 07; 21(1):127-133. PubMed ID: 26820844
[Abstract] [Full Text] [Related]
17. Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome.
Gbadegesin R, Hinkes B, Vlangos C, Mucha B, Liu J, Hopcian J, Hildebrandt F.
Pediatr Nephrol; 2007 Apr 07; 22(4):509-13. PubMed ID: 17216259
[Abstract] [Full Text] [Related]
18. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
Pediatr Int; 2015 Apr 07; 57(1):85-91. PubMed ID: 25225083
[Abstract] [Full Text] [Related]
19. NPHS2 mutations account for only 15% of nephrotic syndrome cases.
Guaragna MS, Lutaif AC, Piveta CS, Souza ML, de Souza SR, Henriques TB, Maciel-Guerra AT, Belangero VM, Guerra-Junior G, De Mello MP.
BMC Med Genet; 2015 Sep 29; 16():88. PubMed ID: 26420286
[Abstract] [Full Text] [Related]
20. Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes.
Wannous H.
Pediatr Nephrol; 2024 Aug 29; 39(8):2413-2422. PubMed ID: 38587559
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
